Elanco proposes divestments of some animal health products in Bayer acquisition

accc
Written By Julie Clarke

The ACCC is seeking views on a divestment undertaking offered by Elanco relating to its proposed acquisition of Bayer Aktiengesellschaft’s animal health business.

See ACCC media release.

See merger register.

Julie Clarke
Previous

ACCC continues investigation into Qantas's stake in Alliance Airlines
Next

Sims weighs in on AAP and media diversity